Market Value1,494,448
Total Holdings73
File Date2023-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VECT / VectivBio Holding AG
KROS / Keros Therapeutics, Inc.
HARP / Harpoon Therapeutics, Inc.
IMRX / Immuneering Corporation
ACET / Adicet Bio, Inc.
IMVT / Immunovant, Inc.
PLRX / Pliant Therapeutics, Inc.
RAIN / Rain Enhancement Technologies Holdco, Inc.
GHRS / GH Research PLC
OLMA / Olema Pharmaceuticals, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
PRME / Prime Medicine, Inc.
TYRA / Tyra Biosciences, Inc.
IMV / IMV Inc
US39536G1058 / GREENLIGHT BIOSCIENCES HOLDINGS PBC A
RNA / Atrium Therapeutics, Inc.
CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock)
IDYA / IDEAYA Biosciences, Inc.
XFOR / X4 Pharmaceuticals, Inc.
VERV / Verve Therapeutics, Inc.
ATXS / Astria Therapeutics, Inc.
ISEE / IVERIC bio Inc Put
VIGL / Vigil Neuroscience, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
ALT / Altimmune, Inc.
ALT / Altimmune, Inc. Call
SRPT / Sarepta Therapeutics, Inc.
GLS / Gelesis Holdings Inc
MLTX / MoonLake Immunotherapeutics
LLY / Eli Lilly and Company
AMLX / Amylyx Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S
EWTX / Edgewise Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
ELDN / Eledon Pharmaceuticals, Inc.
GOSS / Gossamer Bio, Inc.
AKUS / Akouos Inc
GRPH / Graphite Bio, Inc.
KRTX / Karuna Therapeutics, Inc.
PYXS / Pyxis Oncology, Inc.
ICVX / Icosavax, Inc.
RXDX / Prometheus Biosciences Inc
CYTK / Cytokinetics, Incorporated
AVIR / Atea Pharmaceuticals, Inc.
BCEL / Atreca, Inc.
VKTX / Viking Therapeutics, Inc.
PSTX / Poseida Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
ELEV / Elevation Oncology, Inc.
ERAS / Erasca, Inc.
AVTE / Aerovate Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
ETNB / 89bio, Inc.
AMAM / Ambrx Biopharma Inc.
VRDN / Viridian Therapeutics, Inc.
GLTO / Damora Therapeutics, Inc.
TALS / Talaris Therapeutics Inc
COGT / Cogent Biosciences, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
TNGX / Tango Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
STOK / Stoke Therapeutics, Inc.
BMEA / Biomea Fusion, Inc.
PHVS / Pharvaris N.V.
TARS / Tarsus Pharmaceuticals, Inc.
ACLX / Arcellx, Inc.
CABA / Cabaletta Bio, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
AXNX / Axonics, Inc.
AXSM / Axsome Therapeutics, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
BCAB / BioAtla, Inc.
ALXO / ALX Oncology Holdings Inc.
LBPH / Longboard Pharmaceuticals, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
VTYX / Ventyx Biosciences, Inc.
BHVN / Biohaven Ltd.